CCM
IDXX icon

Chilton Capital Management’s Idexx Laboratories IDXX Stock Holding History

Chilton Capital Management’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-10
Closed -$5.62K – 639
2026
Q1 		$5.62K Buy
10
+9
+900% +$5.77K ﹤0.01% 535
2025
Q4 		$677 Buy
+1
New +$681 ﹤0.01% 619
2024
Q4 		– Sell
-9
Closed -$4.55K – 621
2024
Q3 		$4.55K Hold
9
– – ﹤0.01% 534
2024
Q2 		$4.38K Buy
+9
New +$4.52K ﹤0.01% 531

Other funds holding IDXX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Chilton Capital Management's IDXX Position: Q2 2026 in Review

Chilton Capital Management sold out of Idexx Laboratories (IDXX) in Q2 2026, closing a stake of 10 shares — an estimated $5.62K sold.

Chilton Capital Management first reported a position in IDXX in Q2 2024 and held it in 4 quarters. The position peaked at $5.62K in Q1 2026. 1,294 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • Chilton Capital Management reported no remaining Idexx Laboratories position as of Q2 2026 after selling out during the quarter.
  • Chilton Capital Management sold 10 Idexx Laboratories shares in Q2 2026, an estimated $5.62K.
  • Chilton Capital Management first reported a position in Idexx Laboratories in Q2 2024 and held it in 4 quarters.
  • Chilton Capital Management's Idexx Laboratories position peaked at $5.62K in Q1 2026.
  • 1,294 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Chilton Capital Management's 13F filing for Q2 2026, filed 4 Aug 2026.